B2DB — Who said what, where, and when

Rosa Rademakers

VIB-Uantwerp Center for Molecular Neurology

Rosa Rademakers is listed as VIB-Uantwerp Center for Molecular Neurology. Rosa is scheduled to speak at AD/PD 2027 – Advances in Science & Therapy on 16 March 2027.

Compiled from published conference agendas; not yet confirmed by Rosa. Is this you? Claim this profile.

About

Dr. Rademakers received a BSc in Biology (1997), MSc in Biochemistry (1999) and PhD (2004) from the University of Antwerp, Belgium. In 2005 she became postdoctoral fellow in the Neuroscience Department at Mayo Clinic Jacksonville, Florida, USA, where she became faculty member in 2007 and full Professor in 2014. As of 2019, Dr. Rademakers is Scientific Director of the VIB-UA Center for Molecular Neurology and full Professor at the University of Antwerp. Her research is focused on the molecular genetics analyses of frontotemporal lobar degeneration (FTLD) and related disorders. Her laboratory contributed to the discovery of GRN and C9ORF72 as causal disease genes with more recent work expanding into population-based studies focused on the identification of FTLD genetic risk and modifier factors. Dr. Rademakers published over 450 peer‐reviewed articles and reviews. She is the past President of the International Society for Frontotemporal Dementias and a member of the Medical Advisory Coun

Upcoming

AD/PD 2027 – Advances in Science & Therapy 16 March 2027 – 20 March 2027